VASH2 and pancreatic neoplasm: The proportion of specimens with middle/strong staining for VASH2 expression was generally higher in grade 3 pancreatic cancers than in grade 1-2 pancreatic cancers (37/54 [68.5%] vs. 21/48 [43.8%], respectively; P = 0.012).